Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
+1.36%
SPX
+0.85%
IXIC
+0.72%
FTSE
+0.78%
N225
0.00%
AXJO
0.00%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Overview

Loading chart...
Join our newsletter to keep up to date with us!

Key Stats

Market Cap
60.01B
Dividend Yield
0.00%
P/E Ratio
13.46
EPS
40.89
Revenue
14.20B
Avg. Volume
1.02M

About

What does REGN do?
Regeneron Pharmaceuticals, headquartered in Tarrytown, New York, focuses on developing medicines for serious diseases, employing 13,450 people. Its key products include EYLEA, Dupixent, and Libtayo, utilizing advanced technologies like VelociSuite.
Sector
💻 Health Care
IPO
CEO
Employees
15,158
Headquarters
New York, USA
Website
http://www.regeneron.com

Recently from Cashu

publisher logo
Cashu

Regeneron Pharmaceuticals Achieves Major Breakthrough in Allergy Treatment Trials

about 9 hours ago
publisher logo
Cashu

Regeneron Pharmaceuticals Achieves Success in Phase 3 Allergy Treatment Trials

2 days ago
publisher logo
Cashu

Regeneron Pharmaceuticals: Seizing Opportunities in Turbulent Dermatology Market Post-Sanofi Setbacks

4 days ago
Stocks
Health Care
regn
Regeneron Pharmaceuticals
NASDAQ: REGN
+12.34 (+2.22%)
568.175
USD
At close at Sep 11, 20:36 UTC
Summary
News
Signals
Benchmarks
Financials